Molecular Pharmacology Program
The Ronald Blasberg Lab
Ronald Blasberg’s laboratory in the Molecular Pharmacology Program focuses on the development of preclinical, noninvasive, multimodality reporter-gene imaging and its translation into a clinical application. These approaches utilize modern molecular biology, cancer biology, and imaging (MRI, optical imaging, PET, and SPECT) techniques.
Huang R, Vider J, Kovar JL, Olive DM, Mellinghoff IK, Mayer-Kuckuk P, Kircher MF, Blasberg RG. Integrin αvβ3-targeted IRDye 800CW near-infrared imaging of glioblastoma. Clin Cancer Res. 2012 Oct 15;18(20):5731-40. doi: 10.1158/1078-0432.CCR-12-0374. Epub 2012 Aug 22.
Serganova I, Rizwan A, Ni X, Thakur SB, Vider J, Russell J, Blasberg R, Koutcher JA. Metabolic imaging: a link between lactate dehydrogenase A, lactate, and tumor phenotype. Clin Cancer Res. 2011 Oct 1;17(19):6250-61. doi: 10.1158/1078-0432.CCR-11-0397. Epub 2011 Aug 15.
Huang R, Cheung NK, Vider J, Cheung IY, Gerald WL, Tickoo SK, Holland EC, Blasberg RG. MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas. FASEB J. 2011 Dec;25(12):4138-49. doi: 10.1096/fj.11-185033. Epub 2011 Aug 19.
Moroz E, Carlin S, Dyomina K, Burke S, Thaler HT, Blasberg R, Serganova I. Real-time imaging of HIF-1alpha stabilization and degradation. PLoS One. 2009;4(4):e5077. doi: 10.1371/journal.pone.0005077. Epub 2009 Apr 4.
Ronald G. Blasberg, MD
- Physician-scientist Ronald Blasberg focuses on the development of noninvasive imaging paradigms in living organisms using radionuclide and optical reporter systems.
- MD, Albert Einstein College of Medicine
- Brown University
- Paul C. Aebersold Award for Outstanding Achievement in Basic Nuclear Medicine Science, Society of Nuclear Medicine (2008)
- Honorary Doctoral Degree in Medical Sciences, University of Copenhagen (2005)
Get in Touch
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Ronald G. Blasberg discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.